Literature DB >> 21523844

Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.

Jimmy Yu Wai Chan1, Velda Ling Yu Chow, Vivian Way Kay Mok, Ambrose Chung Wai Ho, William Ignace Wei.   

Abstract

BACKGROUND: This study was carried out to determine the role of plasma Epstein-Barr virus (pEBV)-DNA and positron-emission tomography (PET)-CT scan in predicting the outcome of nasopharyngectomy and cervical lymphadenectomy for recurrent nasopharyngeal carcinoma (NPC).
METHODS: Between 2007 and 2009, we recruited patients who had local or regional recurrent NPC after radiotherapy. The relationship between preoperative pEBV-DNA level, maximal standard uptake value (SUVmax), and surgical outcome was analyzed.
RESULTS: Forty-two patients had local tumor recurrence. Their median pEBV-DNA level and SUVmax were 348 copies and 4.7, respectively. Both values were significantly lower than those with palliative nasopharyngectomy. Twenty-two patients had regional failure. Their mean pEBV-DNA level and tumor SUVmax were 626 copies and 7.6, respectively. The metastatic lymph nodes with extracapsular spread had a significantly higher mean SUVmax.
CONCLUSIONS: Preoperative pEBV-DNA and PET-CT predict the surgical outcome of nasopharyngectomy for recurrent NPC. Similarly, PET-CT scan predicts the presence of extracapsular spread of metastatic lymph nodes. These patients may warrant further postoperative adjuvant therapy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523844     DOI: 10.1002/hed.21768

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Surgical salvage of recurrent nasopharyngeal carcinoma.

Authors:  Jimmy Yu Wai Chan
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

3.  Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.

Authors:  Ting Shen; Lin-Quan Tang; Dong-Hua Luo; Qiu-Yan Chen; Pei-Jing Li; Dong-Mei Mai; Shan-Shan Guo; Li-Ting Liu; Chao-Nan Qian; Xiang Guo; Mu-Sheng Zeng; Hao-Yuan Mo; Hai-Qiang Mai
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

4.  Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study.

Authors:  Jingjin Weng; Jiazhang Wei; Jinyuan Si; Yangda Qin; Min Li; Fei Liu; Yongfeng Si; Jiping Su
Journal:  PeerJ       Date:  2017-10-09       Impact factor: 2.984

5.  Interplay of Tumor Spread, Volume and Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: Feasibility of An Integrative Risk Stratification Scheme.

Authors:  Xin Zhou; Youqi Yang; Xiaomin Ou; Tingting Xu; Chunying Shen; Chaosu Hu
Journal:  J Cancer       Date:  2018-10-20       Impact factor: 4.207

6.  Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.

Authors:  Christos K Kontos; Ali Fendri; Abdelmajid Khabir; Raja Mokdad-Gargouri; Andreas Scorilas
Journal:  BMC Cancer       Date:  2013-06-18       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.